BioSpace News Archive

Final topline results remain on target for first half 2020

Cardiovascular Systems, Inc. announced that management will participate and host investor meetings at the following three conferences

Rocket Pharmaceuticals, Inc. announces participation at the following upcoming conferences

Pharma Foods International Co. Ltd. has made available for publication its first-ever study proving that supplementing a post-exercise whey protein regimen with their naturally-produced flagship product PharmaGABATM produces an increase in the body’s already existing resting serum growth hormone level, consequently boosting the formation of lean muscle mass.

PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced that it will present at the H.C. Wainwright 21st Annual Healthcare Conference on September 9, 2019 in New York, NY.

GB Sciences, Inc. announced the appointment to GB Sciences’ executive team of Darin Carpenter as the company’s new Executive Vice President for Operations and General Manager, bringing his extensive and nationally-recognized experience streamlining production, improving product quality, and increasing profitability to GBS.

OKYO Pharma Limited is pleased to announce potent anti-inflammatory activity of OK-113, an in-house discovered proprietary agonist of Chemerin GPCR, in an experimental model of DED in mice.

A collaborative project from the National Comprehensive Cancer Network®, the African Cancer Coalition, the American Cancer Society, and others to improve cancer outcomes in Sub-Saharan Africa enters a new phase in Addis Ababa, Ethiopia.

Nevro Corp. announced that it has completed patient enrollment in its prospective, multicenter Randomized Controlled Trial for the treatment of chronic pain for patients who suffer from Painful Diabetic Neuropathy.

ArQule, Inc. announced that Paolo Pucci, Chief Executive Officer, and Dr. Marc Schegerin, Chief Financial Officer, will attend Citi’s investor conference on Wednesday, September 4, 2019 at the Four Seasons Hotel in Boston, MA.